<DOC>
	<DOC>NCT02721004</DOC>
	<brief_summary>This is an open-label, non-interventional study to evaluate efficacy and safety in rheumatoid arthritis participants receiving tocilizumab as per the product label.</brief_summary>
	<brief_title>Efficacy and Safety Study of RoActemra (Tocilizumab) in Participants With Rheumatoid Arthritis</brief_title>
	<detailed_description />
	<mesh_term>Arthritis</mesh_term>
	<mesh_term>Arthritis, Rheumatoid</mesh_term>
	<criteria>Participants with rheumatoid arthritis receiving tocilizumab as per product label No specific exclusion criteria were specified for this noninterventional trial</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2016</verification_date>
	<keyword>Rheumatoid arthritis</keyword>
	<keyword>RoActemra</keyword>
	<keyword>Tocilizumab</keyword>
</DOC>